Fig. 2: Hazard ratio (and 95% confidence interval) for the association between significant risk factors and time of CV outcomes onset. | Blood Cancer Journal

Fig. 2: Hazard ratio (and 95% confidence interval) for the association between significant risk factors and time of CV outcomes onset.

From: Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms

Fig. 2

Estimates from multivariate Cox proportional hazard models with competitive risks method. Significant (p < 0.05) hazard ratio (HR) estimates kept by backward selection beginning from the full model on all explanatory variables are plotted

Back to article page